Singapore markets open in 3 hours 17 minutes

DiaMedica Therapeutics Inc. (DMAC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.7400+0.1100 (+3.03%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close3.6300
Open3.6000
Bid3.6600 x 900
Ask3.9000 x 900
Day's range3.5800 - 3.8700
52-week range3.0000 - 10.8800
Volume246,486
Avg. volume199,666
Market cap98.883M
Beta (5Y monthly)2.34
PE ratio (TTM)N/A
EPS (TTM)-0.7720
Earnings date10 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est18.20
  • Business Wire

    DiaMedica Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

    MINNEAPOLIS, November 17, 2021--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that Rick Pauls, President and CEO, will participate in a fireside chat at the upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference. Management will also be available for one-on-one meetings.

  • Business Wire

    DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2021 Financial Results

    MINNEAPOLIS, November 10, 2021--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today provided a business update and financial results for the quarter ended September 30, 2021. Management will host a conference call Thursday, November 11, 2021, at 7:00AM Central Time/8:00AM Eastern Time to discuss its business update and third quarter financial results.

  • Business Wire

    DiaMedica Therapeutics to Attend the 12th Annual Craig-Hallum Alpha Select Conference November 16, 2021

    MINNEAPOLIS, November 09, 2021--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that it will be participating in the 12th Annual Craig-Hallum Alpha Select Conference being held virtually on Tuesday, November 16, 2021. Management will be available to participate in one-on-one meetings. Investors and attendees that would like to schedule a meeting with DiaMe